Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-17

Clinical Trial Update: Phase I Study of GSK2982772 in Japanese Healthy Male Participants [Phase 1]

View source ↗

Summary

Phase I trial update of GSK2982772 in Japanese healthy male participants completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GSK2982772 (GSK2982772)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Autoimmune Diseases | Phase 1 | Status: COMPLETED | Results posted: 2019-09-17